4.3 Article

End stage renal disease has an early and continuous detrimental effect on regulatory T cells

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Hematology

Successful Treatment with Belimumab in a Patient with Refractory Systemic Lupus Erythematosus after Initiation of Hemodialysis: Considering the Synergistic Effect of Belimumab and Immunological Burn-Out Phenomenon in End-Stage Renal Disease Patients on Hemodialysis

Kazunori Karasawa et al.

Summary: This case study describes a patient with SLE who progressed to end-stage renal disease (ESRD) and received belimumab treatment for lupus nephritis. The results suggest that ESRD patients may benefit from belimumab therapy, but caution is needed for potential adverse effects during treatment with belimumab.

BLOOD PURIFICATION (2022)

Article Urology & Nephrology

Differential effects of peritoneal and hemodialysis on circulating regulatory T cells one month post initiation of renal replacement therapy

Carlotta Caprara et al.

Summary: This study evaluated longitudinal changes in Treg cells in CKD G5 patients before and after dialysis treatment initiation, showing that peritoneal dialysis (PD) was more effective in increasing Treg levels post initiation of dialysis, potentially contributing to improving inflammatory status and better outcomes for patients with renal dysfunction.

CLINICAL NEPHROLOGY (2021)

Article Urology & Nephrology

Influence of end stage renal disease onCD28expression and T-cell immunity

Erasmia Sampani et al.

Summary: In ESRD patients, CD4+ and CD8+ T-cell counts were significantly reduced, while CD4+ CD28null and CD8+ CD28null cells were significantly increased. The proportions of CD4+ CD28null cells were correlated with serum CRP and albumin levels.

NEPHROLOGY (2021)

Review Immunology

T cell markers recount the course of immunosenescence in healthy individuals and chronic kidney disease

Georgios Lioulios et al.

Summary: Aging leads to significant changes in almost all cellular subpopulations within the immune system, with T lymphocytes undergoing functional and phenotypic alterations. These changes, known as immunosenescence, are also observed in chronic kidney disease, where T cells of young patients resemble those of healthy older individuals. Various surface markers can be used to identify immunosenescent T cells, which may have potential connections with impaired renal function.

CLINICAL IMMUNOLOGY (2021)

Article Biochemistry & Molecular Biology

CD28null and Regulatory T Cells Are Substantially Disrupted in Patients with End-Stage Renal Disease Due to Diabetes Mellitus

Erasmia Sampani et al.

Summary: Diabetes mellitus affects the immune profile of ESRD patients even at the predialysis stage, with more prominent changes observed after hemodialysis commencement.

INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2021)

Article Urology & Nephrology

Immune Dysfunction and Risk of Infection in Chronic Kidney Disease

Maaz Syed-Ahmed et al.

ADVANCES IN CHRONIC KIDNEY DISEASE (2019)

Review Immunology

The role of the immune system in kidney disease

J. Tecklenborg et al.

CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2018)

Review Immunology

Regulatory T cells in renal disease

Maliha A. Alikhan et al.

CLINICAL & TRANSLATIONAL IMMUNOLOGY (2018)

Article Urology & Nephrology

Premature T Cell Senescence in Pediatric CKD

Roshan P. George et al.

JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2017)

Review Urology & Nephrology

Regulatory T cells in kidney disease and transplantation

Min Hu et al.

KIDNEY INTERNATIONAL (2016)

Article Urology & Nephrology

Comparison of Regulatory T Cells in Hemodialysis Patients and Healthy Controls: Implications for Cell Therapy in Transplantation

Behdad Afzali et al.

CLINICAL JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY (2013)

Article Immunology

Regulatory T Cells in Transplantation

K. J. Wood

TRANSPLANTATION PROCEEDINGS (2011)